Aug 11, 2020
It's Lyme Disease Season: 'Be on Guard and Get Tested' Says Leading Health Solutions Developer Quidel Corporation
Jun 19, 2020
Global Spinal Muscular Atrophy Market Outlook to 2027 - Advent of Oral mRNA Splicer for Treatment
Jun 15, 2020
Global Lyme Alliance Welcomes Three New Members to its Board
Jun 12, 2020
PTC Therapeutics Announces 2-year Data from Part 1 of SUNFISH and New Data from JEWELFISH Trials for Risdiplam in Patients with Spinal Muscular Atrophy
Jun 04, 2020
Cure SMA Announces New Funding For Network Of Prominent SMA Clinical Research And Treatment Centers
Jun 02, 2020
Knowing Signs and Symptoms of Lyme Disease Is Critical for Early Detection and Treatment, Says Industry-Leading Quidel
Jun 01, 2020
CytRx Corporation Highlights Orphazyme's Rolling Submission of its New Drug Application with the U.S. FDA for Arimoclomol in Niemann-Pick Disease Type-C
May 13, 2020
Answer ALS is Proud to Announce the Release of New In-Depth Biological and Clinical Datasets to Aid ALS Research
May 11, 2020
Save Nil's Life: Crowdfunding Campaign Created in Fight Against Spinal Muscular Atrophy (SMA) Type 2
Apr 30, 2020
PTC Therapeutics Reports First Quarter 2020 Financial Results and Provides a Corporate Update
Apr 28, 2020
Confirmatory Part 2 of FIREFISH Demonstrates Survival and Motor Milestones Not Seen in Natural History in Infants with Type 1 Spinal Muscular Atrophy
Apr 07, 2020
PTC Announces Regulatory Update on Risdiplam for Spinal Muscular Atrophy (SMA)
Mar 03, 2020
New Lyme Disease Model Could Help Identify Areas of High Risk in the U.S. and Increase Awareness of Disease Spreading
Feb 12, 2020
Global Bell's Palsy Incidence Assessment by Ethnicity & Geography, 2019-2029
Feb 12, 2020
The Center For Lyme Action Honors Leaders At Annual Awards Dinner
Feb 06, 2020
SUNFISH Pivotal Results for Risdiplam (RG7916) Demonstrate Medically Meaningful Benefit in Broadest Age Group of Patients Studied with Type 2 and 3 Spinal Muscular Atrophy
Feb 03, 2020
PTC Therapeutics to Host A Conference Call to Review Part 2 of the SUNFISH Clinical Trial Data at the SMA Europe Conference
Jan 23, 2020
Risdiplam (RG7916) Pivotal FIREFISH Study Demonstrated Statistically Significant Improvement in Infants with Type 1 Spinal Muscular Atrophy
Jan 21, 2020
Clene Nanomedicine Announces First Patient Dosed in the RESCUE-ALS Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with Lead Nanocatalytic Therapeutic, CNM-Au8
Jan 14, 2020
ALS Association Makes Multi-Year Commitment to HEALEY ALS Platform Trial